| 1 |
35499687 | Interplay between PI3K/AKT pathway and heart disorders. | 2022 May 2 |
1 |
| 2 |
33462219 | MEDAG enhances breast cancer progression and reduces epirubicin sensitivity through the AKT/AMPK/mTOR pathway. | 2021 Jan 18 |
1 |
| 3 |
32196840 | Tripartite motif protein 25 is associated with epirubicin resistance in hepatocellular carcinoma cells via regulating PTEN/AKT pathway. | 2020 Jul |
2 |
| 4 |
30816492 | Isoforms S and L of MRPL33 from alternative splicing have isoform‑specific roles in the chemoresponse to epirubicin in gastric cancer cells via the PI3K/AKT signaling pathway. | 2019 May |
2 |
| 5 |
29505745 | Cardioprotective effect of paeonol against epirubicin-induced heart injury via regulating miR-1 and PI3K/AKT pathway. | 2018 Apr 25 |
1 |
| 6 |
29845287 | Antitumor effect of lapatinib and cytotoxic agents by suppression of E2F1 in HER2‑positive breast cancer. | 2018 Jul |
1 |
| 7 |
30216645 | Heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to pharmorubicin by promoting autophagy via PI3K/Akt pathway. | 2018 Nov |
2 |
| 8 |
28476032 | Activation of Akt characterizes estrogen receptor positive human breast cancers which respond to anthracyclines. | 2017 Jun 20 |
1 |
| 9 |
24794111 | Cell membrane mediated (-)-epicatechin effects on upstream endothelial cell signaling: evidence for a surface receptor. | 2014 Jun 15 |
1 |
| 10 |
22529978 | GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells. | 2012 |
5 |
| 11 |
21684102 | Tissue inhibitor of metalloproteinase-1 decreased chemosensitivity of MDA-435 breast cancer cells to chemotherapeutic drugs through the PI3K/AKT/NF-кB pathway. | 2011 Jun |
2 |
| 12 |
21716682 | Effect of Supplementation of Tanshinone IIA and Sodium Tanshinone IIA Sulfonate on the Anticancer Effect of Epirubicin: An In Vitro Study. | 2011 |
4 |